Dhivy (Carbidopa and Levodopa) for Parkinson’s Disease
Overview Dhivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, as well as post-encephalitic parkinsonism and symptomatic parkinsonism caused by carbon monoxide or…